産業情報サービスを提供する世界有力企業です。
メニュー
避妊用医薬品世界市場の発展状況と動向 2024-2030
英文タイトル： Global Contraceptive Drug Market Insights, Forecast to 2030
- レポートID：269441
- 発表時期：2024-04-25
- 訪問回数：168
- ページ数：112
- レポート形式：PDF
- レポート言語：英語、日本語
- グラフ数：131
- レポートカテゴリ： 薬品及びサプリメント
販売価格（消費税別）
販売価格（消費税別）
個人版
詳細マルチユーザー版
詳細企業版
詳細
価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。
価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。
※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は、避妊用医薬品の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に避妊用医薬品市場を分類しています。本レポートでは世界の避妊用医薬品市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Cipla、Bayer、Merck、Teva Pharmaceutical、AbbVie、Pfizer、Reckitt Benckiser、Mankind Pharma、Janssen Pharmaceutical、HLL Lifecare、Mithra Pharmaceuticals
レポートは避妊用医薬品の主要生産者を調査し、主要地域や国の消費状況も提供します。避妊用医薬品の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。
2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。タイプ別市場セグメント：
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の避妊用医薬品生産量、成長率、市場シェアを調査している。
Oral Contraceptives
Contraceptive Injectable
Topical Contraceptive Patch
用途別の市場セグメント：
Hospital Pharmacy
Independent Pharmacy
Online Platform
Clinics
本レポートの詳細内容
本レポートは、世界の避妊用医薬品市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて避妊用医薬品市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
二. 消費面では、避妊用医薬品の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。
三.主要メーカーの避妊用医薬品売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の避妊用医薬品市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。
四.本避妊用医薬品のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章の概要第1章：避妊用医薬品のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 避妊用医薬品の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける避妊用医薬品の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章避妊用医薬品メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：避妊用医薬品の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：避妊用医薬品の主要メーカーの概要を提供し、製品の説明と仕様、避妊用医薬品の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：避妊用医薬品の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。
概要
Contraceptives (birth control pills) are medications that prevent pregnancy. They are one method of birth control.
The global Contraceptive Drug market is projected to grow from US$ 14260 million in 2024 to US$ 20340 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period.
The contraceptive drug market is projected to experience significant growth in the foreseeable future. Factors such as increasing awareness about family planning, rising demand for effective birth control methods, and advancements in contraceptive drug formulations drive market growth. The market is highly competitive, with several pharmaceutical companies offering a wide range of contraceptive drugs. However, challenges such as potential side effects, adherence issues, and cultural barriers may hinder market expansion. Nonetheless, the contraceptive drug market holds promising opportunities, driven by the need for safe and convenient contraceptive options, and the growing focus on reproductive health and family planning worldwide.
Report Covers:
This report presents an overview of global market for Contraceptive Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Contraceptive Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Contraceptive Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Contraceptive Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Contraceptive Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Contraceptive Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Cipla, Bayer, Merck, Teva Pharmaceutical, AbbVie, Pfizer, Reckitt Benckiser, Mankind Pharma and Janssen Pharmaceutical, etc.
Market Segmentation
By Company
Cipla
Bayer
Merck
Teva Pharmaceutical
AbbVie
Pfizer
Reckitt Benckiser
Mankind Pharma
Janssen Pharmaceutical
HLL Lifecare
Mithra Pharmaceuticals
Segment by Type
Oral Contraceptives
Contraceptive Injectable
Topical Contraceptive Patch
Segment by Application
Hospital Pharmacy
Independent Pharmacy
Online Platform
Clinics
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Contraceptive Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Contraceptive Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contraceptive Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.総目録
1 Study Coverage
1.1 Contraceptive Drug Product Introduction
1.2 Market by Type
1.2.1 Global Contraceptive Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral Contraceptives
1.2.3 Contraceptive Injectable
1.2.4 Topical Contraceptive Patch
1.3 Market by Application
1.3.1 Global Contraceptive Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Independent Pharmacy
1.3.4 Online Platform
1.3.5 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Contraceptive Drug Sales Estimates and Forecasts 2019-2030
2.2 Global Contraceptive Drug Revenue by Region
2.2.1 Global Contraceptive Drug Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Contraceptive Drug Revenue by Region (2019-2024)
2.2.3 Global Contraceptive Drug Revenue by Region (2025-2030)
2.2.4 Global Contraceptive Drug Revenue Market Share by Region (2019-2030)
2.3 Global Contraceptive Drug Sales Estimates and Forecasts 2019-2030
2.4 Global Contraceptive Drug Sales by Region
2.4.1 Global Contraceptive Drug Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Contraceptive Drug Sales by Region (2019-2024)
2.4.3 Global Contraceptive Drug Sales by Region (2025-2030)
2.4.4 Global Contraceptive Drug Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Contraceptive Drug Sales by Manufacturers
3.1.1 Global Contraceptive Drug Sales by Manufacturers (2019-2024)
3.1.2 Global Contraceptive Drug Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Contraceptive Drug in 2023
3.2 Global Contraceptive Drug Revenue by Manufacturers
3.2.1 Global Contraceptive Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Contraceptive Drug Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Contraceptive Drug Revenue in 2023
3.3 Global Key Players of Contraceptive Drug, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Contraceptive Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Contraceptive Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Contraceptive Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Contraceptive Drug, Product Offered and Application
3.8 Global Key Manufacturers of Contraceptive Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Contraceptive Drug Sales by Type
4.1.1 Global Contraceptive Drug Historical Sales by Type (2019-2024)
4.1.2 Global Contraceptive Drug Forecasted Sales by Type (2025-2030)
4.1.3 Global Contraceptive Drug Sales Market Share by Type (2019-2030)
4.2 Global Contraceptive Drug Revenue by Type
4.2.1 Global Contraceptive Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Contraceptive Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Contraceptive Drug Revenue Market Share by Type (2019-2030)
4.3 Global Contraceptive Drug Price by Type
4.3.1 Global Contraceptive Drug Price by Type (2019-2024)
4.3.2 Global Contraceptive Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Contraceptive Drug Sales by Application
5.1.1 Global Contraceptive Drug Historical Sales by Application (2019-2024)
5.1.2 Global Contraceptive Drug Forecasted Sales by Application (2025-2030)
5.1.3 Global Contraceptive Drug Sales Market Share by Application (2019-2030)
5.2 Global Contraceptive Drug Revenue by Application
5.2.1 Global Contraceptive Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Contraceptive Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Contraceptive Drug Revenue Market Share by Application (2019-2030)
5.3 Global Contraceptive Drug Price by Application
5.3.1 Global Contraceptive Drug Price by Application (2019-2024)
5.3.2 Global Contraceptive Drug Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Contraceptive Drug Market Size by Type
6.1.1 US & Canada Contraceptive Drug Sales by Type (2019-2030)
6.1.2 US & Canada Contraceptive Drug Revenue by Type (2019-2030)
6.2 US & Canada Contraceptive Drug Market Size by Application
6.2.1 US & Canada Contraceptive Drug Sales by Application (2019-2030)
6.2.2 US & Canada Contraceptive Drug Revenue by Application (2019-2030)
6.3 US & Canada Contraceptive Drug Market Size by Country
6.3.1 US & Canada Contraceptive Drug Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Contraceptive Drug Sales by Country (2019-2030)
6.3.3 US & Canada Contraceptive Drug Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Contraceptive Drug Market Size by Type
7.1.1 Europe Contraceptive Drug Sales by Type (2019-2030)
7.1.2 Europe Contraceptive Drug Revenue by Type (2019-2030)
7.2 Europe Contraceptive Drug Market Size by Application
7.2.1 Europe Contraceptive Drug Sales by Application (2019-2030)
7.2.2 Europe Contraceptive Drug Revenue by Application (2019-2030)
7.3 Europe Contraceptive Drug Market Size by Country
7.3.1 Europe Contraceptive Drug Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Contraceptive Drug Sales by Country (2019-2030)
7.3.3 Europe Contraceptive Drug Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Contraceptive Drug Market Size
8.1.1 China Contraceptive Drug Sales (2019-2030)
8.1.2 China Contraceptive Drug Revenue (2019-2030)
8.2 China Contraceptive Drug Market Size by Application
8.2.1 China Contraceptive Drug Sales by Application (2019-2030)
8.2.2 China Contraceptive Drug Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Contraceptive Drug Market Size by Type
9.1.1 Asia Contraceptive Drug Sales by Type (2019-2030)
9.1.2 Asia Contraceptive Drug Revenue by Type (2019-2030)
9.2 Asia Contraceptive Drug Market Size by Application
9.2.1 Asia Contraceptive Drug Sales by Application (2019-2030)
9.2.2 Asia Contraceptive Drug Revenue by Application (2019-2030)
9.3 Asia Contraceptive Drug Sales by Region
9.3.1 Asia Contraceptive Drug Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Contraceptive Drug Revenue by Region (2019-2030)
9.3.3 Asia Contraceptive Drug Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Contraceptive Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Contraceptive Drug Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Contraceptive Drug Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Contraceptive Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Contraceptive Drug Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Contraceptive Drug Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Contraceptive Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Contraceptive Drug Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Contraceptive Drug Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Contraceptive Drug Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Cipla
11.1.1 Cipla Company Information
11.1.2 Cipla Overview
11.1.3 Cipla Contraceptive Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Cipla Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Cipla Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Contraceptive Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Bayer Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Contraceptive Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Merck Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Information
11.4.2 Teva Pharmaceutical Overview
11.4.3 Teva Pharmaceutical Contraceptive Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Teva Pharmaceutical Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Pharmaceutical Recent Developments
11.5 AbbVie
11.5.1 AbbVie Company Information
11.5.2 AbbVie Overview
11.5.3 AbbVie Contraceptive Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 AbbVie Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AbbVie Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Contraceptive Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Pfizer Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Reckitt Benckiser
11.7.1 Reckitt Benckiser Company Information
11.7.2 Reckitt Benckiser Overview
11.7.3 Reckitt Benckiser Contraceptive Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Reckitt Benckiser Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Reckitt Benckiser Recent Developments
11.8 Mankind Pharma
11.8.1 Mankind Pharma Company Information
11.8.2 Mankind Pharma Overview
11.8.3 Mankind Pharma Contraceptive Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Mankind Pharma Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mankind Pharma Recent Developments
11.9 Janssen Pharmaceutical
11.9.1 Janssen Pharmaceutical Company Information
11.9.2 Janssen Pharmaceutical Overview
11.9.3 Janssen Pharmaceutical Contraceptive Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Janssen Pharmaceutical Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Janssen Pharmaceutical Recent Developments
11.10 HLL Lifecare
11.10.1 HLL Lifecare Company Information
11.10.2 HLL Lifecare Overview
11.10.3 HLL Lifecare Contraceptive Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 HLL Lifecare Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 HLL Lifecare Recent Developments
11.11 Mithra Pharmaceuticals
11.11.1 Mithra Pharmaceuticals Company Information
11.11.2 Mithra Pharmaceuticals Overview
11.11.3 Mithra Pharmaceuticals Contraceptive Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Mithra Pharmaceuticals Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Mithra Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Contraceptive Drug Industry Chain Analysis
12.2 Contraceptive Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Contraceptive Drug Production Mode & Process
12.4 Contraceptive Drug Sales and Marketing
12.4.1 Contraceptive Drug Sales Channels
12.4.2 Contraceptive Drug Distributors
12.5 Contraceptive Drug Customers
13 Market Dynamics
13.1 Contraceptive Drug Industry Trends
13.2 Contraceptive Drug Market Drivers
13.3 Contraceptive Drug Market Challenges
13.4 Contraceptive Drug Market Restraints
14 Key Findings in The Global Contraceptive Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
表と図のリスト
List of Tables
Table 1. Global Contraceptive Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Oral Contraceptives
Table 3. Major Manufacturers of Contraceptive Injectable
Table 4. Major Manufacturers of Topical Contraceptive Patch
Table 5. Global Contraceptive Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Contraceptive Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Contraceptive Drug Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Contraceptive Drug Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global Contraceptive Drug Revenue Market Share by Region (2019-2024)
Table 10. Global Contraceptive Drug Revenue Market Share by Region (2025-2030)
Table 11. Global Contraceptive Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Contraceptive Drug Sales by Region (2019-2024) & (K Units)
Table 13. Global Contraceptive Drug Sales by Region (2025-2030) & (K Units)
Table 14. Global Contraceptive Drug Sales Market Share by Region (2019-2024)
Table 15. Global Contraceptive Drug Sales Market Share by Region (2025-2030)
Table 16. Global Contraceptive Drug Sales by Manufacturers (2019-2024) & (K Units)
Table 17. Global Contraceptive Drug Sales Share by Manufacturers (2019-2024)
Table 18. Global Contraceptive Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global Contraceptive Drug Revenue Share by Manufacturers (2019-2024)
Table 20. Global Key Players of Contraceptive Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 21. Contraceptive Drug Price by Manufacturers 2019-2024 (USD/Unit)
Table 22. Global Contraceptive Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Contraceptive Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptive Drug as of 2023)
Table 24. Global Key Manufacturers of Contraceptive Drug, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Contraceptive Drug, Product Offered and Application
Table 26. Global Key Manufacturers of Contraceptive Drug, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Contraceptive Drug Sales by Type (2019-2024) & (K Units)
Table 29. Global Contraceptive Drug Sales by Type (2025-2030) & (K Units)
Table 30. Global Contraceptive Drug Sales Share by Type (2019-2024)
Table 31. Global Contraceptive Drug Sales Share by Type (2025-2030)
Table 32. Global Contraceptive Drug Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global Contraceptive Drug Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global Contraceptive Drug Revenue Share by Type (2019-2024)
Table 35. Global Contraceptive Drug Revenue Share by Type (2025-2030)
Table 36. Contraceptive Drug Price by Type (2019-2024) & (USD/Unit)
Table 37. Global Contraceptive Drug Price Forecast by Type (2025-2030) & (USD/Unit)
Table 38. Global Contraceptive Drug Sales by Application (2019-2024) & (K Units)
Table 39. Global Contraceptive Drug Sales by Application (2025-2030) & (K Units)
Table 40. Global Contraceptive Drug Sales Share by Application (2019-2024)
Table 41. Global Contraceptive Drug Sales Share by Application (2025-2030)
Table 42. Global Contraceptive Drug Revenue by Application (2019-2024) & (US$ Million)
Table 43. Global Contraceptive Drug Revenue by Application (2025-2030) & (US$ Million)
Table 44. Global Contraceptive Drug Revenue Share by Application (2019-2024)
Table 45. Global Contraceptive Drug Revenue Share by Application (2025-2030)
Table 46. Contraceptive Drug Price by Application (2019-2024) & (USD/Unit)
Table 47. Global Contraceptive Drug Price Forecast by Application (2025-2030) & (USD/Unit)
Table 48. US & Canada Contraceptive Drug Sales by Type (2019-2024) & (K Units)
Table 49. US & Canada Contraceptive Drug Sales by Type (2025-2030) & (K Units)
Table 50. US & Canada Contraceptive Drug Revenue by Type (2019-2024) & (US$ Million)
Table 51. US & Canada Contraceptive Drug Revenue by Type (2025-2030) & (US$ Million)
Table 52. US & Canada Contraceptive Drug Sales by Application (2019-2024) & (K Units)
Table 53. US & Canada Contraceptive Drug Sales by Application (2025-2030) & (K Units)
Table 54. US & Canada Contraceptive Drug Revenue by Application (2019-2024) & (US$ Million)
Table 55. US & Canada Contraceptive Drug Revenue by Application (2025-2030) & (US$ Million)
Table 56. US & Canada Contraceptive Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 57. US & Canada Contraceptive Drug Revenue by Country (2019-2024) & (US$ Million)
Table 58. US & Canada Contraceptive Drug Revenue by Country (2025-2030) & (US$ Million)
Table 59. US & Canada Contraceptive Drug Sales by Country (2019-2024) & (K Units)
Table 60. US & Canada Contraceptive Drug Sales by Country (2025-2030) & (K Units)
Table 61. Europe Contraceptive Drug Sales by Type (2019-2024) & (K Units)
Table 62. Europe Contraceptive Drug Sales by Type (2025-2030) & (K Units)
Table 63. Europe Contraceptive Drug Revenue by Type (2019-2024) & (US$ Million)
Table 64. Europe Contraceptive Drug Revenue by Type (2025-2030) & (US$ Million)
Table 65. Europe Contraceptive Drug Sales by Application (2019-2024) & (K Units)
Table 66. Europe Contraceptive Drug Sales by Application (2025-2030) & (K Units)
Table 67. Europe Contraceptive Drug Revenue by Application (2019-2024) & (US$ Million)
Table 68. Europe Contraceptive Drug Revenue by Application (2025-2030) & (US$ Million)
Table 69. Europe Contraceptive Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 70. Europe Contraceptive Drug Revenue by Country (2019-2024) & (US$ Million)
Table 71. Europe Contraceptive Drug Revenue by Country (2025-2030) & (US$ Million)
Table 72. Europe Contraceptive Drug Sales by Country (2019-2024) & (K Units)
Table 73. Europe Contraceptive Drug Sales by Country (2025-2030) & (K Units)
Table 74. China Contraceptive Drug Sales by Type (2019-2024) & (K Units)
Table 75. China Contraceptive Drug Sales by Type (2025-2030) & (K Units)
Table 76. China Contraceptive Drug Revenue by Type (2019-2024) & (US$ Million)
Table 77. China Contraceptive Drug Revenue by Type (2025-2030) & (US$ Million)
Table 78. China Contraceptive Drug Sales by Application (2019-2024) & (K Units)
Table 79. China Contraceptive Drug Sales by Application (2025-2030) & (K Units)
Table 80. China Contraceptive Drug Revenue by Application (2019-2024) & (US$ Million)
Table 81. China Contraceptive Drug Revenue by Application (2025-2030) & (US$ Million)
Table 82. Asia Contraceptive Drug Sales by Type (2019-2024) & (K Units)
Table 83. Asia Contraceptive Drug Sales by Type (2025-2030) & (K Units)
Table 84. Asia Contraceptive Drug Revenue by Type (2019-2024) & (US$ Million)
Table 85. Asia Contraceptive Drug Revenue by Type (2025-2030) & (US$ Million)
Table 86. Asia Contraceptive Drug Sales by Application (2019-2024) & (K Units)
Table 87. Asia Contraceptive Drug Sales by Application (2025-2030) & (K Units)
Table 88. Asia Contraceptive Drug Revenue by Application (2019-2024) & (US$ Million)
Table 89. Asia Contraceptive Drug Revenue by Application (2025-2030) & (US$ Million)
Table 90. Asia Contraceptive Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 91. Asia Contraceptive Drug Revenue by Region (2019-2024) & (US$ Million)
Table 92. Asia Contraceptive Drug Revenue by Region (2025-2030) & (US$ Million)
Table 93. Asia Contraceptive Drug Sales by Region (2019-2024) & (K Units)
Table 94. Asia Contraceptive Drug Sales by Region (2025-2030) & (K Units)
Table 95. Middle East, Africa and Latin America Contraceptive Drug Sales by Type (2019-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Contraceptive Drug Sales by Type (2025-2030) & (K Units)
Table 97. Middle East, Africa and Latin America Contraceptive Drug Revenue by Type (2019-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Contraceptive Drug Revenue by Type (2025-2030) & (US$ Million)
Table 99. Middle East, Africa and Latin America Contraceptive Drug Sales by Application (2019-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Contraceptive Drug Sales by Application (2025-2030) & (K Units)
Table 101. Middle East, Africa and Latin America Contraceptive Drug Revenue by Application (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Contraceptive Drug Revenue by Application (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America Contraceptive Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 104. Middle East, Africa and Latin America Contraceptive Drug Revenue by Country (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Contraceptive Drug Revenue by Country (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America Contraceptive Drug Sales by Country (2019-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Contraceptive Drug Sales by Country (2025-2030) & (K Units)
Table 108. Cipla Company Information
Table 109. Cipla Description and Major Businesses
Table 110. Cipla Contraceptive Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Cipla Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Cipla Recent Developments
Table 113. Bayer Company Information
Table 114. Bayer Description and Major Businesses
Table 115. Bayer Contraceptive Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Bayer Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Bayer Recent Developments
Table 118. Merck Company Information
Table 119. Merck Description and Major Businesses
Table 120. Merck Contraceptive Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Merck Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Merck Recent Developments
Table 123. Teva Pharmaceutical Company Information
Table 124. Teva Pharmaceutical Description and Major Businesses
Table 125. Teva Pharmaceutical Contraceptive Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Teva Pharmaceutical Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Teva Pharmaceutical Recent Developments
Table 128. AbbVie Company Information
Table 129. AbbVie Description and Major Businesses
Table 130. AbbVie Contraceptive Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. AbbVie Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. AbbVie Recent Developments
Table 133. Pfizer Company Information
Table 134. Pfizer Description and Major Businesses
Table 135. Pfizer Contraceptive Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 136. Pfizer Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Pfizer Recent Developments
Table 138. Reckitt Benckiser Company Information
Table 139. Reckitt Benckiser Description and Major Businesses
Table 140. Reckitt Benckiser Contraceptive Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 141. Reckitt Benckiser Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Reckitt Benckiser Recent Developments
Table 143. Mankind Pharma Company Information
Table 144. Mankind Pharma Description and Major Businesses
Table 145. Mankind Pharma Contraceptive Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 146. Mankind Pharma Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Mankind Pharma Recent Developments
Table 148. Janssen Pharmaceutical Company Information
Table 149. Janssen Pharmaceutical Description and Major Businesses
Table 150. Janssen Pharmaceutical Contraceptive Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 151. Janssen Pharmaceutical Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Janssen Pharmaceutical Recent Developments
Table 153. HLL Lifecare Company Information
Table 154. HLL Lifecare Description and Major Businesses
Table 155. HLL Lifecare Contraceptive Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 156. HLL Lifecare Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. HLL Lifecare Recent Developments
Table 158. Mithra Pharmaceuticals Company Information
Table 159. Mithra Pharmaceuticals Description and Major Businesses
Table 160. Mithra Pharmaceuticals Contraceptive Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 161. Mithra Pharmaceuticals Contraceptive Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Mithra Pharmaceuticals Recent Developments
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Contraceptive Drug Distributors List
Table 166. Contraceptive Drug Customers List
Table 167. Contraceptive Drug Market Trends
Table 168. Contraceptive Drug Market Drivers
Table 169. Contraceptive Drug Market Challenges
Table 170. Contraceptive Drug Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Contraceptive Drug Product Picture
Figure 2. Global Contraceptive Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Contraceptive Drug Market Share by Type in 2023 & 2030
Figure 4. Oral Contraceptives Product Picture
Figure 5. Contraceptive Injectable Product Picture
Figure 6. Topical Contraceptive Patch Product Picture
Figure 7. Global Contraceptive Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Contraceptive Drug Market Share by Application in 2023 & 2030
Figure 9. Hospital Pharmacy
Figure 10. Independent Pharmacy
Figure 11. Online Platform
Figure 12. Clinics
Figure 13. Contraceptive Drug Report Years Considered
Figure 14. Global Contraceptive Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Contraceptive Drug Revenue 2019-2030 (US$ Million)
Figure 16. Global Contraceptive Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 17. Global Contraceptive Drug Revenue Market Share by Region (2019-2030)
Figure 18. Global Contraceptive Drug Sales 2019-2030 ((K Units)
Figure 19. Global Contraceptive Drug Sales Market Share by Region (2019-2030)
Figure 20. US & Canada Contraceptive Drug Sales YoY (2019-2030) & (K Units)
Figure 21. US & Canada Contraceptive Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 22. Europe Contraceptive Drug Sales YoY (2019-2030) & (K Units)
Figure 23. Europe Contraceptive Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 24. China Contraceptive Drug Sales YoY (2019-2030) & (K Units)
Figure 25. China Contraceptive Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Asia (excluding China) Contraceptive Drug Sales YoY (2019-2030) & (K Units)
Figure 27. Asia (excluding China) Contraceptive Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Contraceptive Drug Sales YoY (2019-2030) & (K Units)
Figure 29. Middle East, Africa and Latin America Contraceptive Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 30. The Contraceptive Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 31. The Top 5 and 10 Largest Manufacturers of Contraceptive Drug in the World: Market Share by Contraceptive Drug Revenue in 2023
Figure 32. Global Contraceptive Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 33. Global Contraceptive Drug Sales Market Share by Type (2019-2030)
Figure 34. Global Contraceptive Drug Revenue Market Share by Type (2019-2030)
Figure 35. Global Contraceptive Drug Sales Market Share by Application (2019-2030)
Figure 36. Global Contraceptive Drug Revenue Market Share by Application (2019-2030)
Figure 37. US & Canada Contraceptive Drug Sales Market Share by Type (2019-2030)
Figure 38. US & Canada Contraceptive Drug Revenue Market Share by Type (2019-2030)
Figure 39. US & Canada Contraceptive Drug Sales Market Share by Application (2019-2030)
Figure 40. US & Canada Contraceptive Drug Revenue Market Share by Application (2019-2030)
Figure 41. US & Canada Contraceptive Drug Revenue Share by Country (2019-2030)
Figure 42. US & Canada Contraceptive Drug Sales Share by Country (2019-2030)
Figure 43. U.S. Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 44. Canada Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 45. Europe Contraceptive Drug Sales Market Share by Type (2019-2030)
Figure 46. Europe Contraceptive Drug Revenue Market Share by Type (2019-2030)
Figure 47. Europe Contraceptive Drug Sales Market Share by Application (2019-2030)
Figure 48. Europe Contraceptive Drug Revenue Market Share by Application (2019-2030)
Figure 49. Europe Contraceptive Drug Revenue Share by Country (2019-2030)
Figure 50. Europe Contraceptive Drug Sales Share by Country (2019-2030)
Figure 51. Germany Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 52. France Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 53. UK Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 54. Italy Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 55. Russia Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 56. China Contraceptive Drug Sales Market Share by Type (2019-2030)
Figure 57. China Contraceptive Drug Revenue Market Share by Type (2019-2030)
Figure 58. China Contraceptive Drug Sales Market Share by Application (2019-2030)
Figure 59. China Contraceptive Drug Revenue Market Share by Application (2019-2030)
Figure 60. Asia Contraceptive Drug Sales Market Share by Type (2019-2030)
Figure 61. Asia Contraceptive Drug Revenue Market Share by Type (2019-2030)
Figure 62. Asia Contraceptive Drug Sales Market Share by Application (2019-2030)
Figure 63. Asia Contraceptive Drug Revenue Market Share by Application (2019-2030)
Figure 64. Asia Contraceptive Drug Revenue Share by Region (2019-2030)
Figure 65. Asia Contraceptive Drug Sales Share by Region (2019-2030)
Figure 66. Japan Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 67. South Korea Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 68. China Taiwan Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 69. Southeast Asia Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 70. India Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Contraceptive Drug Sales Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Contraceptive Drug Revenue Market Share by Type (2019-2030)
Figure 73. Middle East, Africa and Latin America Contraceptive Drug Sales Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Contraceptive Drug Revenue Market Share by Application (2019-2030)
Figure 75. Middle East, Africa and Latin America Contraceptive Drug Revenue Share by Country (2019-2030)
Figure 76. Middle East, Africa and Latin America Contraceptive Drug Sales Share by Country (2019-2030)
Figure 77. Brazil Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 78. Mexico Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 79. Turkey Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 80. Israel Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 81. GCC Countries Contraceptive Drug Revenue (2019-2030) & (US$ Million)
Figure 82. Contraceptive Drug Value Chain
Figure 83. Contraceptive Drug Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル（英語、日本語）が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能；基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期：英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込（納品後、ご請求書送付）。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合：
レポート選択
見積もり依頼
メールでのご注文
入手（英語版は2〜4営業日、日本語版は8〜10営業日）
決済（後払い）
クレジットカード決済の場合：
レポート選択
ウェブサイトでのご注文
決済
入手（英語版は2〜4営業日、日本語版は8〜10営業日）
ご利用ガイド
関連リンク
お電話でのお問い合わせ
9:00-18:00 (土日・祝日を除く)
